RightFit
Not yet recruitingNot applicable

NaviCam Patency Capsule to Verify Gastrointestinal Patency

A Prospective, Single Center Clinical Trial Assessing the Efficacy and Safety of the NaviCam Patency Capsule to Verify Gastrointestinal Patency

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
22 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: X-rays, Pills

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria: * Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months. * Patients suffering from Crohn's Disease * Patients with long-term use of non-steroidal anti-inflammatory drugs. * Patients with abdominal symptoms related to intestinal stricture. * Patients with chronic inflammatory diseases. * Patients with difficulty with balloon-assisted endoscopy (BAE). * Patients with a history of small bowel obstruction. * Patients with a history of intestinal resection surgery. Exclusion Criteria: * Patients with esophageal obstruction or swallowing disorder diseases. * Patients who are ineligible for surgery or refuse to undergo any abdominal surgery. * Patients with known allergies or other contraindications or intolerance to the medications used in this study. * Patients with pacemakers or other implanted electronic devices such as cochlear implants, magnetic metal drug infusion pumps, neurostimulators. * Pregnant women * Patients currently enrolled in another drug or device clinical trial. * Other conditions deemed unsuitable for inclusion by the investigator.

Study sites (1)

IL